If you made any changes in Pure these will be visible here soon.

Personal profile


Dongbin completed his Bachelor of Science in Biology and Master of Science in Immunology, before doing his PhD and Postdoctoral research at the Garvan Institute in Sydney under the supervision of Prof Jonathan Sprent.

At Garvan, Dongbin used preclinical models to develop novel vaccine technologies that can massively expand tumour killing T cells. Dongbin is extending these exciting findings into more clinically relevant settings in the Translational Antigen Discovery Laboratory at Monash University.

Education/Academic qualification

Immunology, PhD, Garvan Institute of Medical Research (New South Wales)

19 Jul 201024 Jun 2015

Award Date: 31 Jul 2015

Research area keywords

  • cancer vaccine
  • preclincal development
  • dendritic cells
  • T cells
  • adjuvants
  • nanoparticles
  • immunotherapies


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or